670898 external_news 1699284217 1699284217 A team of infectious disease researchers at the Emory University School of Medicine, working with colleagues from the Georgia Institute of Technology, has found via clinical trial that fecal transplants after kidney transplantation reduce the susceptibility of patients to infections by multi-drug-resistant organisms (MDROs). In their study, reported in the journal Science Translational Medicine, the group tested the impact of fecal microbiota transfer (FMT) on kidney transplant patients receiving care at Emory Transplant Center, in Atlanta. One of the researchers involved in the study is Roth E. Conrad, an Ocean Science and Engineering Ph.D. scholar in the School of Biological Sciences. 

]]> 2023-11-02 1278 1275